Defiance ETFs, LLC

Mutual Fund

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1732541 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$496,730

+$121,637 QoQ

Shares Held

1,000

+19.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,079

of 1,735 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Defiance ETFs, LLC holds $776,633 across 3 Biotechnology names. VRTX ranks #1 (64.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,000	$496,730
2	REGN	Regeneron Pharmaceuticals, Inc.	394	$245,674
3	AVXL	Anavex Life Sciences Corp.	13,216	$34,229

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$496,730	1,000	+19.0%	Shares	Sole	2026-08-14
2026-03-31	$375,093	840	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.